Abbott Labs (ABT)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Abbott Labs | ABT | Healthcare | Medical Devices | 95 | 11.0% |
Current Price (05/13) | $109.88 | |||
CAPS Rating (Rate this stock on CAPS) | ![]() |
|||
Expected Income Statement | ||||
Current Sales | 43,075.0 | |||
Sales Growth Forecast | 6.4% | |||
Net Profit Margin | 23.5% | |||
Projected Shares Outstanding | 1,759.38 | |||
EPS - Five year Forecast | $7.86 | |||
Average P/E Ratio | 22.0 | |||
Projected Average Price | $172.97 | |||
Price Appreciation (Annualized) | 9.5% | |||
Annual Dividend Yield | 1.5% | |||
Projected Annual Return | 11.0% | |||
Quality | ||||
Financial Strength | 99 | 24.8 | ||
EPS Stability | 93 | 23.2 | ||
Industry Sales Growth Rate | 10.0% | 8.1 | ||
Industry Net Profit Margin | 15.5% | 19.0 | ||
Calculated Quality Rating | 76.2 | |||
Fool CAPS | ||||
Total Players
2484
Outperforms
96
Underperforms
All-Stars (518)
506
Outperforms (98%)
12
Underperforms
|
||||
Fundamental Data Updated: 02/11/2022 |